Please login or register first to view this content.
Urological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Testosterone Therapy for Hypogonadism Not Tied to Increased CV Risk
Testosterone Replacement Therapy Tlando Now Available
ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
Sparsentan Gets Priority Review for IgA Nephropathy
Zerbaxa Approved for Complicated Pediatric Intra-abdominal, Urinary Tract Infections
PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD
Renal Denervation Offers Sustained Blood Pressure Reduction
Enrollment Paused in Trials Evaluating BCX9930 for Complement-Mediated Diseases
Oral Tebipenem Effectively Treats Complicated UTI, Pyelonephritis
FDA Says No to Vadadustat Approval Due to Safety Concerns
FDA Approves Oral Testosterone Replacement Therapy Tlando
Elobixibat Improves Constipation in Chronic Kidney Disease
Positive Efficacy Findings Prompt Early Stop of Empagliflozin CKD Trial
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI
Cefepime-Taniborbactam Bests Meropenem in Complicated UTI Trial
MV140 Vaccine May Prevent Recurrent Urinary Tract Infections
Inappropriate Opioid, Gabapentinoid Prescribing in CKD Still a Problem
More Data Needed to Make Decision on Bardoxolone in Alport Syndrome
